Intermittent Fasting Safety: Who Should Avoid It, the Danger Signs, and How to Do It Safely

Intermittent fasting has become popular as a way to manage weight and health, and for many people it is reasonably safe. But not everyone should do it, and for some groups fasting carries real, even life threatening, risk. This article helps you find out first whether you are in a group that needs caution or should avoid it, and which signs mean you should stop right away.

One thing to say up front: the information here is population level guidance for prevention and understanding, not a diagnosis or a personal prescription. If you have an underlying condition, take medication, are pregnant or breastfeeding, or are in a risk group, always talk to a doctor before starting.

Intermittent Fasting Does Not Suit Everyone

In adults who are overweight or obese and otherwise healthy, most side effects of intermittent fasting are mild, such as hunger, headache, or fatigue. A meta-analysis of randomized trials did not find the rate of these common side effects to be significantly higher than in people who did not fast. But this evidence comes from general adults and is mostly short term follow up, so it cannot be applied to higher risk groups. In other words, a reassuring safety profile in healthy, overweight adults over a few weeks or months says little about someone who is pregnant, frail, underweight, or living with diabetes on medication.

Although fasting is reasonably safe for many adults studied, people who are pregnant or breastfeeding, growing children and teenagers, frail older adults, people with an eating-disorder history or malnutrition, and people with diabetes using certain medicines should not start on their own. Individual risk assessment and a professional plan matter more than treating one diagnosis or age as an automatic prohibition.

Diabetes: The Low Blood Sugar Risk to Watch Most Closely

The central risk lies with people who have diabetes and use insulin, sulfonylureas (such as glibenclamide, glipizide, or gliclazide), or other insulin secretagogues. Actual hypoglycemia risk depends on the medicine and insulin regimen, previous hypoglycemia, kidney function, fasting duration, and other factors. People using these medicines should not start or change a fasting pattern on their own. Anyone assessed as potentially suitable needs specialist assessment, an individualized clinician-created safety plan, and close follow-up. Never reduce, delay, omit, or stop medication independently.

The 2026 review combined diverse fasting patterns and therapies and had extreme heterogeneity (four HbA1c trials, n=280, I²=98.1%). It therefore does not provide a stable estimate of differential benefit in insulin versus oral-therapy users. The more certain point is that insulin and insulin secretagogues increase hypoglycemia risk and require specialist assessment and a clinician-created safety plan.

People with type 1 diabetes have higher risks of hypoglycemia and ketoacidosis during fasting and should not start on their own. Some evidence indicates that selected adults may fast with specialist assessment, an individualized clinician-created safety plan, and close follow-up from a specialist diabetes team. Type 1 diabetes is therefore a high-risk condition requiring specialist selection, not an unqualified universal prohibition.

The single most important caution: if you use insulin or a sulfonylurea, do not start fasting on your own without talking to a doctor.

These medicines increase hypoglycemia risk during fasting, so specialist assessment, an individualized clinician-created safety plan, and close follow-up are required. Never change medication independently. Sources: ADA Standards of Care 2026, Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus (PMID 31003482), and IDF-DAR Practical Guidelines 2021.

Groups That Should Clearly Avoid It

Beyond people with diabetes on high risk medicines, several other groups are advised to avoid intermittent fasting. This is especially true for anyone whose underlying condition is unstable or not yet under control, who should not start fasting on their own until it is controlled and a doctor has been consulted.

During pregnancy or breastfeeding, do not start TRE or fasting for weight control without professional review. Ramadan-fasting evidence is mostly observational, heterogeneous, and incomplete for rare serious outcomes, so it cannot establish either safety or certain harm. Anyone pregnant, planning pregnancy, or breastfeeding should consult their obstetric/maternity team and a registered dietitian before changing eating timing.

People with a history of or risk for eating disorders such as anorexia, bulimia, or binge eating should not do intermittent fasting, because the structure of restricting when you eat can trigger or worsen disordered eating, even in a lighter pattern like 16:8. The evidence linking fasting to disordered eating is observational, so it shows an association rather than proving a direct cause, but the risk in this group is enough to advise against it.

People who are underweight or malnourished should not start fasting on their own because a further energy deficit can cost muscle mass. Refeeding syndrome is not an expected consequence of ordinary 16:8. Risk arises with severe malnutrition, major unintentional weight loss, electrolyte depletion, or little/no intake for several consecutive days. BMI below 18.5 is one flag, not a stand-alone diagnosis.

Older adults with frailty, unintentional weight loss, malnutrition, low muscle mass, cognitive impairment, or limited support need risk assessment before restricting eating time. Age alone is not an automatic contraindication, although long-term evidence in frail older adults remains limited.

People with severe kidney or liver disease should not fast on their own without medical supervision, because fasting can bring fluid and electrolyte instability, impaired gluconeogenesis, and altered drug clearance. This group should fast only under a doctor’s care.

Children and teenagers who are still growing are another group that should not do intermittent fasting, since their bodies need energy and nutrients for growth.

Danger Signs That Mean Stop Right Away

If you do fast, being able to recognize these warning signs is the most important thing.

Shaking, palpitations, sweating, hunger, dizziness, or confusion may be compatible with hypoglycemia but are not specific. A conscious person with diabetes who can swallow should stop the fast and follow the existing diabetes-team hypoglycemia plan or a device alert specified in that plan. This article does not interpret a meter/CGM value or set a treatment dose.

For severe confusion, seizure, unresponsiveness, or inability to swallow, give nothing by mouth and call emergency services immediately. While waiting, follow the person’s existing emergency plan.

Chest pain during a fast is a danger sign that means stop right away and seek urgent medical care rather than waiting to see whether it passes.

Refeeding syndrome requires clinician/dietitian assessment and monitoring. A person with little or no intake for more than 5–10 days, severe malnutrition, major weight loss, or electrolyte abnormalities should not use a DIY “gradual refeeding” plan. Swelling, breathing difficulty, palpitations, or marked weakness after food is restarted warrants urgent assessment.

Possible ketoacidosis in diabetes includes marked thirst/frequent urination with nausea or vomiting, abdominal pain, deep rapid breathing, fruity breath, drowsiness, or elevated ketones. Stop fasting and contact the diabetes team or obtain urgent assessment immediately according to the sick-day/DKA plan; call emergency services for persistent vomiting, inability to keep fluids down, abnormal breathing, or altered mental status.

Before You Start: How to Stay Safe and Who Should See a Doctor First

If you take regular medicines—especially medicines prescribed with food, affected by dehydration or major dietary change, or requiring close monitoring—take the complete medication list to a doctor or pharmacist before fasting. Do not change the timing, dose, or use of a medicine on your own.

After professional assessment finds fasting appropriate, choose an eating window that fits the person’s goals and life without assuming fasting hours must be progressively increased. Follow medical fluid limits, stop for abnormal symptoms, and follow the clinician-created safety plan with close follow-up when medication can cause hypoglycemia.

Here are steps you can start with safely:

1. Assess yourself first. If you are in a risk group, such as diabetes on medication, pregnancy or breastfeeding, a history of eating disorders, being underweight, or being frail and older, talk to a doctor before starting.
2. Take your medication list to a doctor or pharmacist if you use glucose lowering or regular medicines, to assess risk and adjust timing.
3. Review the existing hypoglycemia plan with the diabetes team, including how to respond to device alerts under that plan.
4. Choose an eating window after appropriate assessment. There is no requirement to progressively lengthen a fast; follow fluid restrictions and stop for abnormal symptoms.
5. Follow the clinician-created safety plan with close follow-up, especially when medication can cause hypoglycemia.

Intermittent fasting has its place, but the safest starting point is knowing which group you are in and letting a doctor help you decide together when it matters.

This content provides general information from research and professional guidance for population-level learning. It is not diagnosis, treatment, or individualized advice about food, exercise, glucose monitoring, or medication. Consult your treating clinician or another qualified professional, especially if you have a medical condition, take medication, are pregnant or breastfeeding, have an eating-disorder history, plan a prolonged fast, or develop abnormal symptoms. Never adjust or stop medication on your own. Call emergency services for confusion, seizure, unconsciousness, inability to swallow, chest pain, abnormal breathing, or suspected diabetic ketoacidosis.